Sunday, November 22, 2026

Donald Trump’s ‘tariffs coming soon’ remark sinks Pharma stocks yet again

Date:

India’s Pharma stocks fell up to 4% on Tuesday, June 17, after US President Donald Trump told reporters on board the Air Force One, that tariffs on the Pharma sector are ‘coming soon.’The Nifty Pharma index fell as much as 2.5% in response.
Granules India is the top loser on the Nifty Pharma index, declining up to 4%, while those of Lupin, Aurobnido and Natco Pharma also fell 3% each.

Earlier in April, after announcing the reciprocal tariffs across 60 countries, which excluded the Pharma sector, Trump had mentioned that tariffs on the Pharma sector will be at “never seen before” levels.”Pharma tariffs are going to come in at levels you haven’t really seen before. We are looking at pharmaceuticals as a separate category. We will be announcing that sometime in the near future, and not too distant future. It’s under review right now,” Trump had said back in April.Currently, Pharma, as a sector, is being investigated by the US Commerce Department, under Section 232, which is used to determine the effects the imports of a goods or service could have on national security. Section 232 is exempt from the baseline and reciprocal tariffs.The Nifty Pharma index is currently trading 2.2% lower, while extending its year-to-date losses to 8%.First Published: Jun 17, 2025 2:56 PM IST

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

CLSA sees better US-India trade outlook; expects Fed and RBI to raise rates in December

The US is likely to push ahead with trade...

‘Trump has cost us’: After midterm losses, MAGA asks if it’s over

As Republicans faced a nationwide drubbing in Tuesday’s midterm...

Prashant Jain sees 12-15% annual returns from Indian equities over 3-5 years

Question We've had a very painful period for the equity...

Raamdeo Agrawal sees FIIs return as earnings improve and valuations turn attractive

Question Looking at the valuation compression across the market, are...